Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations
- PMID: 11231030
- DOI: 10.1016/s0022-510x(00)00492-5
Prevalence and pattern of cognitive impairment in systemic lupus erythematosus patients with and without overt neuropsychiatric manifestations
Abstract
The prevalence and pattern of cognitive impairment in systemic lupus erythematosus (SLE) patients with (NPSLE) and without (nSLE) overt neuropsychiatric manifestations were investigated. Fifty-two nSLE patients, 23 NPSLE patients and 27 healthy controls were evaluated with a battery of standardized neuropsychological and psychological tests. Disease duration, disease activity index, and current corticosteroid therapy were collected. Cognitive impairment was identified in 14 (26.9%) and in 12 (52.2%) of subjects with nSLE and NPSLE, respectively. Both SLE groups showed a significant impairment compared with controls on tasks assessing verbal and non-verbal long-term memory, and visuoconstructional abilities. In addition, NPSLE patients reported worse performances than both nSLE patients and controls on task evaluating short-term visuospatial memory. NPSLE subjects were significantly more anxious and depressed compared to both nSLE subjects and controls. By multivariate analysis, only depression levels, among clinical variables, significantly predicted cognitive performance. This study shows that cognitive impairment occurs frequently in both nSLE and NPSLE subjects. The higher frequency in NPSLE may be related to coexisting depressive disturbances.
Similar articles
-
Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.Arthritis Rheum. 2008 Nov 15;59(11):1639-46. doi: 10.1002/art.24189. Arthritis Rheum. 2008. PMID: 18975359
-
Systemic lupus erythematosus patients with past neuropsychiatric involvement are associated with worse cognitive impairment: a longitudinal study.Lupus. 2016 May;25(6):637-44. doi: 10.1177/0961203315624022. Epub 2015 Dec 23. Lupus. 2016. PMID: 26700182
-
Cognition, MRS neurometabolites, and MRI volumetrics in non-neuropsychiatric systemic lupus erythematosus: preliminary data.Cogn Behav Neurol. 2005 Sep;18(3):159-62. doi: 10.1097/01.wnn.0000181543.05064.4b. Cogn Behav Neurol. 2005. PMID: 16175019
-
Assessment of the Hospital Anxiety and Depression Scale (HADS) performance for the diagnosis of anxiety in patients with systemic lupus erythematosus.Rheumatol Int. 2017 Dec;37(12):1999-2004. doi: 10.1007/s00296-017-3819-x. Epub 2017 Sep 22. Rheumatol Int. 2017. PMID: 28940018 Review.
-
[Neuropsychiatric systemic lupus erythematosus (1st part). Cases definitions and diagnosis and treatment of central nervous system and psychiatric manifestations of systemic lupus erythematosus].Rev Med Interne. 2012 Sep;33(9):491-502. doi: 10.1016/j.revmed.2012.03.356. Epub 2012 May 11. Rev Med Interne. 2012. PMID: 22579860 Review. French.
Cited by
-
Neuropsychological patterns in systemic lupus erythematosus patients with depression.Arthritis Res Ther. 2007;9(3):R48. doi: 10.1186/ar2203. Arthritis Res Ther. 2007. PMID: 17504538 Free PMC article.
-
Impact of memory impairment on employment status in persons with systemic lupus erythematosus.Arthritis Rheum. 2007 Dec 15;57(8):1453-60. doi: 10.1002/art.23090. Arthritis Rheum. 2007. PMID: 18050187 Free PMC article.
-
Anti-alpha-internexin autoantibody from neuropsychiatric lupus induce cognitive damage via inhibiting axonal elongation and promote neuron apoptosis.PLoS One. 2010 Jun 15;5(6):e11124. doi: 10.1371/journal.pone.0011124. PLoS One. 2010. PMID: 20559547 Free PMC article.
-
Challenges of Diagnosing Cognitive Dysfunction With Neuropsychiatric Systemic Lupus Erythematosus in Childhood.Arthritis Care Res (Hoboken). 2017 Oct;69(10):1449-1459. doi: 10.1002/acr.23163. Epub 2017 Aug 29. Arthritis Care Res (Hoboken). 2017. PMID: 27992660 Free PMC article. Review.
-
Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics.Signal Transduct Target Ther. 2025 Mar 17;10(1):102. doi: 10.1038/s41392-025-02168-0. Signal Transduct Target Ther. 2025. PMID: 40097390 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical